BusinessGeneral NewsHealthcareIndustryInternationalUncategorized

Global Pemphigoid Drug Market : The dynamics of Developed & Developing Countries Growth Speed Up || Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Sanofi, Akari Therapeutics, Plc, Johnson & Johnson Services, Inc , AbbVie Inc, Amgen Inc

Global Pemphigoid Drug Market By Type (Bullous Pemphigoid, Cicatricial Pemphigoid, Pemphigoid Gestationis), Medication Type (Corticosteroids, Anti-Biotics, Steroid-Sparing Immunosuppressant Drugs and Others), Route of Administration Type (Oral, Injectable and Topical), Distribution Channel Type (Online Pharmacy, Direct Tenders, Retailers and Others) End- Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Analysis: Global Pemphigoid Drug Market

Global pemphigoid drug market to grow at a substantial CAGR in the forecast period of 2019-2026. Growing pemphigoid population and exposure to certain toxin or change in environment may increase the pemphigoid disease are the key drivers for market growth.

Request for sample copy or PDF with (Market Segments, Forecast, Key player’s and TOC) @ https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-pemphigoid-drug-market&raksh

Market Definition: Global Pemphigoid Drug Market

Pemphigoid is a rare autoimmune skin disorder that causes the body’s own immune system to attack the layer of skin and separates the bottom layer of skin from above layers, resulting in blistering, itching, redness and rashes. This disease mostly develops in geriatric population.

According to statistics published in European Medicines Agency, 2.5 in every 10,000 people were diagnosed with bullous pemphigoid in the European Union in the year of 2018. This growing incidence of pemphigoid disease, vulnerable aging population and accelerating the demand of newer therapies are key factors for rise in market growth.

Market Drivers

  • Increase in prevalence rate of pemphigoid disease worldwide
  • Exposure to certain toxin or change in environment may increase the pemphigoid disease
  • Rising awareness about treatment and technological advancement is driving the growth of market
  • Rapid adoption of newer formulations and novel dosage forms

Market Restraints

  • Effective treatment is either unavailable or unaffordable
  • Patent expiry from many companies and introduction of generic drugs of branded version is expected to restrain the growth if the market
  • Inadequate knowledge about pemphigoid in some developing countries

Segmentation: Global Pemphigoid Drug Market

By Type

  • Bullous Pemphigoid
  • Cicatricial Pemphigoid
  • Pemphigoid Gestationis

By Medication Type

  • Corticosteroids
    • Prednisone
    • Clobetasol propionate
  • Anti-biotics
    • Doxycycline
  • Steroid-sparing immunosuppressant drugs
    • Azathioprine
    • Mycophenolate mofetil
  • Others

By Route of administration

  • Oral
  • Injectable
  • Topical

By Distribution Channel

  • Online Pharmacy
  • Direct Tenders
  • Retailers
  • Others

 By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific
  • Middle East & Africa
    • South Africa
    • Egypt
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Rest of Middle East & Africa

Browse Detailed TOC, Tables, Figures, Charts and Companies @ https://www.databridgemarketresearch.com/toc?dbmr=global-pemphigoid-drug-market&raksh

Key Developments in the Market:

In April 2019, Akari Therapeutics, Plc reported the Phase II trial results where the trial demonstrated well toleration of Nomacopan (Coversin), given subcutaneously in three elderly patients (>65 years) for the treatment of bullous pemphigoid. If approved it will shift from the conventional therapies to novel disease specific treatment for the patients suffering from pemphigoid.

In August 2018, Immune Pharmaceuticals, Inc received Orphan Drug designation from the US FDA for Bertilimumab for the treatment of bullous pemphigoid. If approved, it will be the potential commercial milestone for Immune Pharmaceuticals, Inc

Competitive Analysis:

Global pemphigoid drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Pemphigoid Drug market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

Few of the major competitors currently working in the global pemphigoid drug market are Novartis AG, Takeda Pharmaceutical Company Limited, TWi Pharmaceuticals, Inc, Immune Pharmaceuticals, Inc., Dompé farmaceutici S.p.A., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Sanofi, Akari Therapeutics, Plc, Johnson & Johnson Services, Inc , AbbVie Inc, Amgen Inc , Celgene Corporation, Bausch Health, Bristol-Myers Squibb Company, Merck & Co. Inc., GlaxoSmithKline plc, Mylan N.V., Merz Pharma and many others.

Research Methodology: Global Pemphigoid Drug Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global pemphigoid drug market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

Want Full Report? Enquire Here @ https://www.databridgemarketresearch.com/inquire-before-buying?dbmr=global-pemphigoid-drug-market&raksh

About Data Bridge Market Research:

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing [email protected] . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475
Mail: [email protected]
https://databridgemarketresearch.com

Report Rating
Close